M. Furness

发表

AN EFFICIENT SYNTHESIS OF 2-ARYL AND 2-ALKENYL-3-ALKOXY-CYCLOHEXENONES BY A MODIFIED STILLE REACTION

J. P. Bowen, T. Robinson, D. Goldsmith, 1999 .

Probes for Narcotic Receptor-Mediated Phenomena. 27.1 Synthesis and Pharmacological Evaluation of Selective δ-Opioid Receptor Agonists from 4-[(αR)-α-(2S,5R)-4-Substituted-2,5-dimethyl-1-piperazinyl-3-methoxybenzyl]- N,N-diethylbenzamides and Their Enantiomers

K. Rice, A. Coop, R. Rothman, 2000 .

Regulatory considerations of pharmaceutical solid polymorphism in Abbreviated New Drug Applications (ANDAs).

Lawrence X. Yu, Lawrence X Yu, A. Raw, 2004, Advanced drug delivery reviews.

Scientific Considerations of Pharmaceutical Solid Polymorphism in Abbreviated New Drug Applications

Lawrence X. Yu, Edwin P. Ramos, A. Hussain, 2003, Pharmaceutical Research.

Antiangiogenic agents: studies on fumagillin and curcumin analogs.

J. Arbiser, J. P. Bowen, T. Robinson, 2005, Current pharmaceutical design.

Discriminative Stimulus Effects of the Nonpeptidic δ-Opioid Agonist SNC80 in Rhesus Monkeys

N. Mello, K. Rice, S. Negus, 1999 .

Discriminative Stimulus Effects of the Nonpeptidic d-Opioid Agonist SNC 80 in Rhesus Monkeys 1

N. Mello, K. Rice, S. Negus, 1999 .

Studies of tolerance and dependence with the delta-opioid agonist SNC80 in rhesus monkeys responding under a schedule of food presentation.

K. Rice, S. Negus, M. Brandt, 2001, The Journal of pharmacology and experimental therapeutics.

Antinociceptive effects of delta-opioid agonists in Rhesus monkeys: effects on chemically induced thermal hypersensitivity.

N. Mello, K. Rice, S. Negus, 2001, The Journal of pharmacology and experimental therapeutics.

Delta opioid antagonist effects of buprenorphine in rhesus monkeys.

N. Mello, K. Rice, S. Negus, 1999 .

Delta opioid antagonist effects of buprenorphine in rhesus monkeys

N. Mello, S. Negus, J. Bidlack, 2002, Behavioural pharmacology.

Diaryldimethylpiperazine ligands with μ- and δ-opioid receptor affinity: Synthesis of (+)-4-[(αR)-α-(4-allyl-(2S, 5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]- N-ethyl-N-phenylbenzamide and (-)-4-[(αR)-α-(2S, 5S)-dimethylpiperazin-1-yl)-(3-hydroxyphenyl)methyl]-N-ethyl-N -phenylbenzamide

Judith L. Flippen-Anderson, Arthur E. Jacobson, Clifford George, 2003 .

Receptor-selective antagonism of opioid antinociception in female versus male rats

R. Craft, K. Rice, A. Tseng, 2001, Behavioural pharmacology.